The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance

Microbiology

Volumn 144, Issue 10, 1998, Pages 2697-2704

  Banerjee, Asesh ^a,b   Sugantino, Michele ^a   Sacchettini, James C ^a,c   Jacobs Jr , William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Drug resistance; Ethionamide; inhA gene; Isoniazid; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL ENZYME; ISONIAZID; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; ESCHERICHIA COLI; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; POSIBACTERIA; PROKARYOTA;

EID: 0031733687     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-144-10-2697     Document Type: Article

References (35)

1. Baldock, C., Rafferty, J. B., Sedelnikova, S. E., Baker, P. J., Stuitje, A. R., Slabas, A. R., Hawkes, T. R. & Rice, D. W. (1996). A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274, 2107-2110.
2. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W. R., Jr (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230.
3. Bartolome, B., Jubete, Y., Martinez, E. & De La Cruz, F. (1991). Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives. Gene 102, 75-78.
4. Dessen, A., Quemard, A., Blanchard, J. S., Jacobs, W. R., Jr & Sacchettini, J. C. (1995). Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267, 1638-1641.
5. Donnelly-Wu, M. K., Jacobs, W. R., Jr & Hatfull, G. F. (1993). Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol Microbiol 7, 407-417.
6. Fleischmann, R. D., Adams, M. D., White, O. & 37 other authors (1995). Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512.
7. Genetics Computer Group (1995). Program Manual: Wisconsin Sequence Analysis Package, Version 8, UNIX. Madison, WI: Genetics Computer Group, Madison.
8. Hanukoglu, I. & Gutfinger, T. (1989). cDNA sequence of adrenodoxin reductase. Identification of NADP-binding sites in oxidoreductases. Eur J Biochem 180, 479-484.
9. Heym, B., Honore, N., Truffot-Pernot, C., Banerjee, A., Schurra, C., Jacobs, W. R., Jr, van Embden, J. D., Grosset, J. H. & Cole, S. T. (1994). Implications of multidrug resistance for the future of chemotherapy of tuberculosis: a molecular study. Lancet 344, 293-298.
10. Jacobs, W. R., Jr, Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R., Jones, W., Barletta, R. G. & Bloom, B. R. (1991). Genetic systems for mycobacteria. Methods Enzymol 204, 537-555.
11. Johnsson, K., King, D. S. & Schultz, P. G. (1995). Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Amer Chem Soc 117, 5009-5010.
12. Kapur, V., Li, L. L, Hamrick, M. R. & 11 other authors (1996). Rapid mycobacterium species assignment and unambiguous mutations associated with antimicrobial resistance in Mycobacterium tuberculosis. Arch Pathol Lab Med 119, 131-138.
13. Kikuchi, S., Takeuchi, T., Yasui, M., Kusaka, T. & Kolattukudy, P. E. (1989). A very long-chain fatty acid elongation system in Mycobacterium avium and a possible mode of action of isoniazid on the system. Agric Biol Chem 53, 1689-1698.
14. Klein, B., Pawlowski, K., Horicke-Grandpierre, C., Schell, J. & Topfer, R. (1992). Isolation and characterization of a cDNA from Cuphea lanceolata encoding a β-ketoacyl-ACP reductase. Mol Gen Genet 233, 122-128.
15. Mdluli, K., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S., Stover, C. K. & Barry, C. E. (1996). Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis 174, 1085-1090.
16. Musser, J. M. (1995). Antimicrobial agent resistance in mycobacteria - molecular genetic insights. Clin Microbiol Rev 8, 496-514.
17. Musser, J. M., Kapur, V., Williams, D. L, Kreiswirth, B. N. & Vansoolingen, D. (1996). Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing - restricted array of mutations associated with drug resistance. J Infect Dis 173, 196-202.
18. Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C, Bittman, R., Jacobs, W. R., Jr & Blanchard, J. S. (1995). Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34, 8235-8241.
19. Rawlings, M. & Cronan, J. E., Jr (1992). The gene encoding Escherichia coli acyl carrier protein lies within a cluster of fatty acid biosynthetic genes. J Biol Chem 267, 5751-5754.
20. Ristow, M., Mohlig, M., Rifai, M., Schatz, H., Feldmann, K. & Pfeiffer, A. (1995). New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 346, 502-503.
21. Rouse, D. A., Li, Z. M., Bai, G. H. & Morris, S. L. (1995). Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 39, 2472-2477.
22. Rozwarski, D. A., Grant G. A., Barton, D. H. R., Jacobs, W. R., Jr & Sacchettini, J. C. (1998). Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 278, 98-102.
23. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
24. Shen, Z. W. & Byers, D. M. (1996). Isolation of Vibrio harveyi acyl carrier protein and the fabG, acpP, and fabF genes involved in fatty acid biosynthesis J Bacteriol 178, 571-573.
25. Slabas, A. R., Chase, D., Nishida, I. & 7 other authors (1992). Molecular cloning of higher-plant 3-oxoacyl-(acyl carrier protein) reductase. Sequence identities with the nodG-gene product of the nitrogen-fixing soil bacterium Rhizobium meliloti. Biochem J 283, 321-326.
26. Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T. & Jacobs, W. R., Jr (1990). Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4, 1911-1919.
27. Snider, D. E., Raviglione, M. & Kochi, A. (1994). Global burden of tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control, pp. 3-12. Edited by B. R. Bloom. Washington, DC: American Society for Microbiology.
28. van Soolingen, D., Hermans, P. W., de Haas, P. E., Soll, D. R. & van Embden, J. D. (1991). Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. Clin Microbiol 29, 2578-2586.
29. Studier, F. W., Rosenberg, A. H., Dunn, J. J. & Dubendorff, J. W. (1990). Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185, 60-89.
30. Telenti, A., Honore, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E. & Cole, S. T. (1997). Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35, 719-723.
31. Toomey, R. E. & Wakil, S. J. (1966). Studies on the mechanism of fatty acid synthesis. XV. Preparation and general properties of β-ketoacyl acyl carrier protein reductase from Escherichia coli. Biochim Biophys Acta 116, 189-197.
32. Victor, T. C., Warren, R., Butt, J. L & 9 other authors (1997). Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrugresistant tuberculosis J Med Microbiol 46, 847-857.
33. Wheeler, P. R. & Anderson, P. M. (1996). Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A +. Biochem J 318, 451-457.
34. World Health Organization (1997). The World Health Report 1997. Geneva, Switzerland: World Health Organization.
35. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. (1992). The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591-593.